Abstract:Bovine mastitis, the inflammation of the mammary gland, affects the quality and quantity of milk yield. Mastitis control relies on single or multiple combinations of antibiotic therapy. Due to increasing antibiotic resistance in pathogens, the intramammary infusion of lactic acid bacteria (LAB) has been considered as a potential alternative to antibiotics for treating and preventing bovine mastitis through the improvement of the host immunity. Probiotic effects are a strain-dependent characteristic; therefore, candidate LAB strains have to be evaluated efficiently to find out the ones with the best potential. Here, we investigated LAB strains originally isolated from feedlot cattle’s environment regarding their ability in inducing the Toll-like receptor (TLR)-triggered inflammatory responses in bovine mammary epithelial (BME) cells in vitro. The BME cells were pre-stimulated with the LAB strains individually for 12, 24, and 48 h and then challenged with Escherichia coli-derived lipopolysaccharide (LPS) for 12 h. The mRNA expression of selected immune genes—interleukin 1 alpha (IL-1α), IL-1β, monocyte chemotactic protein 1 (MCP-1), IL-8, chemokine (C-X-C motif) ligand 2 (CXCL2), and CXCL3 were quantified by real-time quantitative PCR (RT-qPCR). Results indicated that pretreatment with some Lactobacillus strains were able to differentially regulate the LPS inflammatory response in BME cells; however, strain-dependent differences were found. The most remarkable effects were found for Lactobacillus acidophilus CRL2074, which reduced the expression of IL-1α, IL-1β, MCP-1, IL-8, and CXCL3, whereas Lactobacillus rhamnosus CRL2084 diminished IL-1β, MCP-1, and IL-8 expression. The pre-stimulation of BME cells with the CRL2074 strain resulted in the upregulated expression of three negative regulators of the TLRs, including the ubiquitin-editing enzyme A20 (also called tumor necrosis factor alpha-induced protein 3, TNFAIP3), single immunoglobin IL-1 single receptor (SIGIRR), and Toll interacting protein (Tollip) after the LPS challenge. The CRL2084 pre-stimulation upregulated only Tollip expression. Our results demonstrated that the L. acidophilus CRL2074 strain possess remarkable immunomodulatory abilities against LPS-induced inflammation in BME cells. This Lactobacillus strain could be used as candidate for in vivo testing due to its beneficial effects in bovine mastitis through intramammary infusion. Our findings also suggest that the BME cells immunoassay system could be of value for the in vitro evaluation of the immunomodulatory abilities of LAB against the inflammation resulting from the intramammary infection with mastitis-related pathogens.

Analysis of Treating Dairy Cow Mastitis Using Recombinant Plasmid Containing Lysozyme Gene

Environmental Release Experiment on Treating Dairy Cow Mastitis Using Gene Pharmaceutical

Investigation of Pathogen Bacteria Causing Dairy Subclinical Mastitis in Dairy Farm of Main Regions in Zhejiang Province

Transcriptome Sequencing Analysis of Bovine Mammary Epithelial Cells Induced by Lipopolysaccharide.

Therapeutic Effect of Nisin Z on Subclinical Mastitis in Lactating Cows.

Observasion of Nisin for Bovine Mastitis Therapy

Prevalence, Genetic Diversity, and Antimicrobial Susceptibility Profiles of Staphylococcus Aureus Isolated from Bovine Mastitis in Zhejiang Province, China.

Changes of main constituents in milk from cows with subclinical mastitis caused by Streptococcus agalactiae after intramammary infused with Nisin

Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows.

Analysis of Differentially Expressed Micrornas in Bovine Mammary Epithelial Cells Treated with Lipoteichoic Acid.

A Study on Differential Biomarkers in the Milk of Holstein Cows with Different Somatic Cells Count Levels

Investigation on Pathogenic Bacteria Causing Subclinical Mastitis on a Dairy Farm with High Somatic Cell Counts

In Vitro Inhibitory Effects of Nisin on Major Pathogenic Bacteria of Bovine Mastitis

Isolation and Identification of Pathogenic Bacteria from Endometritis in Dairy Cows and Bacteriostasis of ε-polylysine

Therapeutic effect of polysaccharide fraction of Atractylodis macrocephalae Koidz . in bovine subclinical mastitis

Distribution of Major Mastitis-Causing Bacteria and Common Antimicrobial Drugs in Milk.

Impact of yeast and lactic acid bacteria on mastitis and milk microbiota composition of dairy cows

Preliminary study on the protective function of bovine single chain antibody against Staphylococcus aureus

Evaluation of the Immunomodulatory Ability of Lactic Acid Bacteria Isolated from Feedlot Cattle Against Mastitis Using a Bovine Mammary Epithelial Cells In Vitro Assay

Bacterial Community Profiling of Milk Samples As a Means to Understand Culture-Negative Bovine Clinical Mastitis.

Screening of lactic acid bacteria from the milk of Sahiwal cows and characterization of their probiotic potential for preventing bovine mastitis